{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:37Z","timestamp":1793237677318,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00014"],"award-info":[{"award-number":["75N93021C00014"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["P01 AI097092-07"],"award-info":[{"award-number":["P01 AI097092-07"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["2R01AI145870-06"],"award-info":[{"award-number":["2R01AI145870-06"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:58:51Z","timestamp":1774465131000},"page":"4153-4168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"Mitali","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Puente-Massaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Mart\u00ednez-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsoi Ying","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Abdeljawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey V.","family":"Ravetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-5505","authenticated-orcid":false,"given":"Irene","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.021_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib3","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038778","article-title":"Influenza Hemagglutinin Structures and Antibody Recognition","volume":"10","author":"Wu","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2026.03.021_bib4","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.03.021_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib6","series-title":"Recommended Composition of Influenza Virus Vaccines for Use","year":"2024"},{"key":"10.1016\/j.ymthe.2026.03.021_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.021_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ymthe.2026.03.021_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126408","article-title":"Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact","volume":"42","author":"Taaffe","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.03.021_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.03.021_bib11","article-title":"Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine","volume":"9","author":"Bullard","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2026.03.021_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-019-0126-4","article-title":"A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains","volume":"4","author":"Broecker","year":"2019","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib13","article-title":"Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice","volume":"7","author":"Corder","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2026.03.021_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41541-023-00728-5","article-title":"A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses","volume":"8","author":"Liu","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib15","article-title":"Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib16","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1172\/JCI122895","article-title":"Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance","volume":"128","author":"Liu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.03.021_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2370087","article-title":"Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults","volume":"20","author":"Boyce","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.03.021_bib18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/14760584.2016.1203261","article-title":"Recombinant hemagglutinin influenza vaccine provides broader spectrum protection","volume":"15","author":"Dunkle","year":"2016","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae559","article-title":"Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial","volume":"11","author":"Grant","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.03.021_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.03.021_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a haemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.021_bib22","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Antonietta Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.021_bib23","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41564-024-01860-1","article-title":"A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses","volume":"9","author":"Bakkers","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib24","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1074\/jbc.M114.620534","article-title":"Immunosilencing a highly immunogenic protein trimerization domain","volume":"290","author":"Sliepen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.03.021_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2389095","article-title":"Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ymthe.2026.03.021_bib26","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1128\/JVI.00808-15","article-title":"Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer","volume":"89","author":"Lee","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115379119","article-title":"Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions","volume":"119","author":"Milder","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.021_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-022-00463-3","article-title":"Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity","volume":"7","author":"Hendin","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fcgamma Receptor Function and the Design of Vaccination Strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.03.021_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4933-10-14","article-title":"Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011\u20132012 influenza vaccine season","volume":"10","author":"Daniela Frasca","year":"2013","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.ymthe.2026.03.021_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974016","article-title":"RIG-I and TLR-7\/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine","volume":"13","author":"Jangra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Ching-Lin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.021_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/v14081816","article-title":"Stabilisation of Viral Membrane Fusion Proteins in Prefusion Conformation by Structure-Based Design for Structure Determination and Vaccine Development","volume":"14","author":"Ebel","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.03.021_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41467-024-45480-z","article-title":"A general computational design strategy for stabilizing viral class I fusion proteins","volume":"15","author":"Gonzalez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.021_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade0424","article-title":"A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine","volume":"14","author":"Chang","year":"2022","journal-title":"Sci. Translat. Med."},{"key":"10.1016\/j.ymthe.2026.03.021_bib37","doi-asserted-by":"crossref","first-page":"eade6422","DOI":"10.1126\/scitranslmed.ade6422","article-title":"Rational design of a highly immunogenic prefusionstabilized F glycoprotein antigen for a respiratory syncytial virus vaccine","volume":"15","author":"Ye Che","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.021_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.021_bib39","article-title":"Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg4535","article-title":"First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes","volume":"13","author":"Guthmiller","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.021_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00333-19","article-title":"Development of Influenza B Universal Vaccine Candidates Using the \u201cMosaic\u201d Hemagglutinin Approach","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","article-title":"Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle","volume":"634","author":"Caserta","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.021_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126269","article-title":"A recombinant N2 neuraminidase-based CpG 1018(R) adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters","volume":"42","author":"Hoxie","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.03.021_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.021_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-020-2838-z","article-title":"Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection","volume":"588","author":"Bournazos","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.021_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.03.021_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102688","article-title":"Protocol for performing and optimizing differential scanning fluorimetry experiments","volume":"4","author":"Wu","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymthe.2026.03.021_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54620-4","article-title":"A vaccine platform targeting lung-resident memory CD4(+) T-cells provides protection against heterosubtypic influenza infections in mice and ferrets","volume":"15","author":"Ko","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.021_bib50","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"Steel","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib51","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.021_bib52","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.021_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1097349","article-title":"Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses","volume":"11","author":"Puente-Massaguer","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.021_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103132","article-title":"Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate","volume":"62","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.03.021_bib55","first-page":"3791","article-title":"Influenza virus propagation in embryonated chicken eggs","volume":"10","author":"Brauer","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2026.03.021_bib56","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41467-021-26499-y","article-title":"A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.021_bib57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.03.021_bib58","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.021_bib59","article-title":"An In Vitro Microneutralization Assay for Influenza Virus Serology","volume":"2","author":"Cuevas","year":"2022","journal-title":"Curr. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:26:10Z","timestamp":1793237170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626002066"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}